Darren Cline

Insider Reports History

Entity
Individual
Location
35 Cambridge Park Drive, Cambridge, MA
Signature
/s/ Pamela Connealy, Attorney-in-Fact for Darren Cline
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Darren Cline:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PLIANT THERAPEUTICS, INC. Director Common Stock (Right to Buy) 26.8K $55.7K $2.08 Jun 13, 2024 Direct
Pyxis Oncology, Inc. Director Stock Option (Right to Buy) 37K $36.2K $0.98 Mar 31, 2025 Direct
IMPEL PHARMACEUTICALS INC Director Stock Option (right to buy) 13.2K Jun 16, 2023 Direct
GW PHARMACEUTICALS PLC U.S. Chief Commercial Officer Ordinary Shares 0 May 5, 2021 Direct
GW PHARMACEUTICALS PLC U.S. Chief Commercial Officer Share Options 0 May 5, 2021 Direct
IMPEL PHARMACEUTICALS INC Director No securities beneficially held. 0 Apr 12, 2023 Direct

Insider Reports Filed by Darren Cline

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PYXS Pyxis Oncology, Inc. Mar 31, 2025 1 $36.2K 4 Apr 2, 2025 Director
PLRX PLIANT THERAPEUTICS, INC. Jun 13, 2024 1 $0 4 Jun 17, 2024 Director
PYXS Pyxis Oncology, Inc. Mar 26, 2024 1 $0 4 Mar 28, 2024 Director
IMPL IMPEL PHARMACEUTICALS INC Jun 16, 2023 1 $0 4 Jun 20, 2023 Director
PLRX PLIANT THERAPEUTICS, INC. Jun 7, 2023 1 $0 4 Jun 8, 2023 Director
IMPL IMPEL PHARMACEUTICALS INC Apr 12, 2023 1 $0 4 Apr 14, 2023 Director
IMPL IMPEL PHARMACEUTICALS INC Apr 12, 2023 0 $0 3 Apr 13, 2023 Director
PYXS Pyxis Oncology, Inc. Mar 24, 2023 1 $0 4 Mar 28, 2023 Director
PLRX PLIANT THERAPEUTICS, INC. Mar 6, 2023 1 $0 4 Mar 8, 2023 Director
PLRX PLIANT THERAPEUTICS, INC. Mar 6, 2023 0 $0 3 Mar 8, 2023 Director
PYXS Pyxis Oncology, Inc. Mar 31, 2022 1 $0 4 Apr 4, 2022 Director
PYXS Pyxis Oncology, Inc. Dec 8, 2021 1 $93.9K 4 Dec 9, 2021 Director
PYXS Pyxis Oncology, Inc. Oct 7, 2021 1 $0 4 Oct 12, 2021 Director
PYXS Pyxis Oncology, Inc. Oct 7, 2021 0 $0 3 Oct 7, 2021 Director
GWPH GW PHARMACEUTICALS PLC May 5, 2021 8 $0 4 May 7, 2021 U.S. Chief Commercial Officer